your market intelligence analyst
Search Results
241 results
Your search is now limited to «Gilead» expert search.
Balm of Gilead Salve has the compounds that come exactly as found in the fresh herbs of Balm of Gilead, St. John's Wort and Arnica.
More from Middle East North Africa Financial Network (MENAFN):
ENDPOINTS 10/11/2019 10:22
Filgotinib, Gilead and Galapagos’ rival JAK drug, is currently under US review but investors are nervous it too will suffer the same fate.
More from ENDPOINTS:
Gilead plans to file a New Drug Application (NDA) for filgotinib for the treatment of rheumatoid arthritis in the United States including the FINCH 1 and FINCH 3 Week 52 data later this year.
More from Pharmaceutical Business Review:
FierceMedicalDevices 10/11/2019 06:51
Gilead and Galapagos have said that 52-week phase 3 data for JAK1 inhibitor filgotinib in rheumatoid arthritis are consistent with earlier readouts.
More from FierceMedicalDevices:
Business Wire 10/10/2019 16:05
Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the third quarter 2019 and provide a business update.
More from Business Wire:
FierceBiotech 10/10/2019 09:37
Chasing AbbVie, Gilead files for approval of filgotinib in Japan Gilead Sciences has filed for approval of JAK1 inhibitor filgotinib in Japan.
More from FierceBiotech:
Xconomy 10/08/2019 11:57
Merdad Parsey has been appointed chief medical officer of Gilead Sciences (NASDAQ: GILD.
More from Xconomy:
Pharmafile 10/08/2019 05:56
News has broken that the Scottish Medicines Consortium (SMC) has chosen to approve the use of Gilead’s chimeric antigen receptor T cell (CAR-T) therapy Yescarta (axicabtagene ciloleucel) on the NHS in Scotland.
More from Pharmafile:
InPharmaTechnologist 10/07/2019 10:56
... Truvada’s high efficacy with statistically significant improvements in renal and bone safety, which can be an important consideration as people at risk increasingly use PrEP for longer periods of time,” said Daniel O’Day, CEO at Gilead Sciences.
More from InPharmaTechnologist:
FiercePharmaManufacturing 10/07/2019 09:55
Gilead called on to 'significantly cut' HIV med Descovy's price in PrEP.
More from FiercePharmaManufacturing:
MarketWatch 10/07/2019 08:40
Gilead Sciences Inc. said Monday it named Merdad Parsey its chief medical officer, effective Nov. 1. Parsey was most recently a senior vice president of early clinical development at Roche Holding AG's Genentech Inc. Merdad will report directly to Chief Executive Daniel O'Day. The biopharmaceutical company's stock, which eased 0.3% in light premarket trading, is little changed year to date through Friday, while the iShares Nasdaq Biotechnology ETF has gained 3.2% and the S&P 500 has advanced 17.8%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.
More from MarketWatch:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications